The committee also called for feasibility studies on how to end the use of wild caught animals in research, amid concerns about supply and the limited amount of time being allowed for the move to entirely captive-bred animals. "Those are all very positive developments," says Roger Lemon, a neuroscientist at University College London. "Those were the three critical things for the future of non-human primate research. It is a victory for common sense really." The changes were also welcomed by industry groups, who had expressed concern about the new directive. "We consider this as a step towards striking the balance between the protection of laboratory animals, biomedical-research reality and patients' needs," says Brian Ager, director-general of the European Federation of Pharmaceutical Industries and Associations in Brussels. Animals-rights groups, however, have complained bitterly about the amendments. The Dr Hadwen Trust, a UK charity that funds non-animal techniques and campaigns against animal experiments, accused committee members of "complacency and cowardice for abandoning laboratory animals in the face of dishonest industry tactics".
Nature
April 21, 2009
Original web page at Nature



